23andMe had all the signs of a success story. The Aboutunicorn brand became synonymous with consumer-facing genetic testing, went public, and was once valued at $6 billion.
But then, it all came tumbling down. Sales for 23AndMe kits began to fall, attempts to raise new funds hit a wall, the company struggled to find a product that would bring in recurring revenue, and it was still dealing with the fallout from a major data breach.
23andMe filed for bankruptcyand put its assets up for salein March 2025. But, more concerning than the success or failure of a particular company, was this question: What would happen to 23andMe's vast trove of highly personal customer data? We aren't just talking about usernames and birthdays. 23andMe has DNA profilesfor millions of users.
Well, now we know who bought 23andMe and, most importantly, now owns all the DNA data from the company's customers.
On Monday, Regeneron Pharmaceuticals announcedthat it would acquire most of 23andMe's assets for $256 million. According to Regeneron Pharmaceuticals, the acquisition includes 23andMe's Personal Genome Service, Total Health and Research Services business lines, and the trove of customers' DNA samples and genetic data.
This Tweet is currently unavailable. It might be loading or has been removed.
Regeneron Pharmaceuticals will not, however, be acquiring 23andMe's online doctor and telehealth service known as Lemonaid Health, which will be shuttered.
Based in Tarrytown, NY, Regeneron Pharmaceuticals is a biotechnology company that researches and develops medicines for cancer, cardiovascular disease, and other diseases. The company is currently valued at more than $64 billion.
Regeneron Pharmaceuticals placed a bid for 23andMe as part of a court-supervised sales process. The bid requires Regeneron Pharmaceuticals to comply with the company's existing privacy policies and applicable laws.
Conspiracy-minded consumers might revolt at the idea of a big pharma brand acquiring their DNA profile. However, in a press release, Regeneron has promised "to comply with the Company’s privacy policies" and "process all customer personal data in accordance with the consents, privacy policies and statements, terms of service, and notices currently in effect." Further, the company assured customers it has "a proven track record of safeguarding personal genetic data, and we assure 23andMe customers that we will apply our high standards for safety and integrity to their data." A court-appointed expert will also submit a report about potential privacy and security impacts to the court by June 10.
If the name "Regeneron" sounds familiar, it may be because the company received mainstream attention in 2020 after the company created an experimental treatment for COVID-19 called REGN-COV2. President Donald Trump was treated with the drug when he was infected with COVID-19 in October of that year.
While 23andMe's demise is certainly notable, a most lasting debate will undoubtedly be had regarding the sale of 15 million customers' genetic data.
“Your DNA and your family health history should not be a corporate asset," said J.B. Branch, Big Tech accountability advocate for the consumer rights advocacy group Public Citizen, in a statement. "Of course, Regeneron will promise to ‘respect consent’ and ‘uphold privacy policies.’ Those are bare minimal legal requirements. But time and again these companies fail consumers."
Topics Cybersecurity Politics
Previous:Shrinking the President
Adam Savage is back with kids spin'Star Wars' inspired 9/11 terrorists, says Margaret AtwoodHackers exploit smart thermometer to steal casino informationTesla clashes with NTSB over fatal Model X crash investigationMark Zuckerberg equivocates when asked about tracking loggedReview: 'God of War' is a superb game, equal parts fresh and familiarWoah, Tom Hardy is completely unrecognisable as Al CaponeKanye's philosophy book explains why he deleted his Twitter historyBox that unlocks iPhones is the hottest new gadget for policePennsylvania schools are arming their teachers with very useful mini baseball batsCritics say 'Westworld' Season 2 is bigger and betterFired NFL cheerleader pushes back against gender bias in the leagueFCC filing shows GoogleAustralia has been breaking records for heat in AprilMarshall Islands back historic IMO deal to slash shipping emissionsNo girl's period should force her to miss school, and this startup is making sure of thatJames Comey reveals he's a secret John Green fanA first look at 'Harry Potter: Hogwarts Mystery' mobile gameThe best iPhone 8 casesMedium app release notes make fun of Mark Zuckerberg's testimony How to download Netflix movies and shows for offline viewing The Tamagotchi Connection is back and you can pre Horizon Robotics invests in Didi’s self RCB vs. DC 2024 livestream: Watch IPL for free Why Trump can dynamite a sacred, protected mountain to build the wall DC vs. LSG 2024 livestream: Watch IPL for free How to block websites on iPhone 2024 iPad Pro benchmarks crush every PC we've tested for past 6 months — except one Huawei releases smart driving app HIMA · TechNode ByteDance reportedly earns $110 billion in 2023 · TechNode TikTok might launch ChatGPT Tottenham Hotspur vs. Man United 2024 livestream: Watch Women’s FA Cup Final for free Greta Thunberg nails the #2019in5words challenge How to pair Apple AirPods with an Android device Car tech firm iMotion shares slump 13% in Hong Kong debut · TechNode Conservationists are petitioning for a dugong emoji Match report: Many more singles are using AI to date in 2025 OpenAI down: 'Too many concurrent requests' ChatGPT error message explained The giant burn scar on Australia's Kangaroo Island is horrific Douyin beta tests AI